Skip to main content

Table 2 RANKL, OPG and CD4+ T cell count in overall cohort

From: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults

WEEK

sRANKL

sOPG

RANKL/OPG ratio

CD4 + T cells

week 0

7.79 (2.83–12.01) (n = 48)

34.19 (26.53–45.75) (n = 48)

0.21 (0.08–0.36)

200 (86–280) (n = 48)

week 12

8.03 (3.72–11.01) (n = 45)

40.52 (28.55–53.67) (n = 45)

0.18 (0.11–0.30)

300 (202–400) (n = 48)

week 24

5.75 (2.88–9.41) (n = 45)

35.83 (25.54–50.66) (n = 45)

0.17 (0.07–0.29)

340 (240–470) (n = 47)

week 48

5.92 (3.07–11.98) (n = 43)

36.10 (26.19–55.82) (n = 42)

0.16 (0.09–0.35)

360 (250–535) (n = 45)

week 96

6.03 (1.02–11.31) (n = 34)

38.24 (29.82–50.47) (n = 33)

0.15 (0.05–0.30)

450 (280–600) (n = 43)

  1. Values are depicted as median and interquartile range (IQR). sRANKL and OPG in picograms/ml (pg/ml) and CD4+ T cells as cells/μl